Collegium Pharmaceutical, Inc.
corporate_fare Company Profile
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for COLL at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Collegium Pharmaceutical Projects 4% Revenue Growth for 2026, Refinances Debt for Significant Interest Savings
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$780.57M
Net Income
$62.87M
Diluted EPS
$1.73
Op. Cash Flow
$329.32M
Free Cash Flow
$327.58M
Gross Profit
$463.26M
Operating Income
$179.64M
Cash & Equivalents
$231.25M
Debt / Equity
0.00×
Net Margin
8.1%
Shares Outstanding
31.71M sh
Source: 10-K · filed 2026-02-26 · accession 0001628280-26-011992
show_chartPrice Chart
Loading chart...
feed COLL - Filings & News (Page 2)
COLL
Jan 08, 2026, 8:06 AM EST
Price at Filing:
$47.62
Real-time Price:
$24.72
Change:
-$22.90 (-48%)
Market Cap:
$768.184M